Pegalan, Fred Vincent F.
HRN: 01-55-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2023
CO-AMOXICLAV 625MG (TAB)
06/05/2023
06/12/2023
PO
625mg
Bid
S/P Exlap, Resection And Anastomosis, Lavage, Jp Drain Application
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes